Abstract

ObjectiveTo assess the panel composition of the two most important guideline developers in urology as equity and acceptability, important domains in clinical guideline development, require broad stakeholder representation. MethodsFollowing a predefined protocol, we identified all current AUA and EAU guideline documents. Two authors independently abstracted data including guideline topic, number and roles of panel members, voting status, and academic rank. We determined panel member gender (woman, man, or nonbinary) and racialization (White or non-White) status based on name, internet picture, pronouns used, bios available, and gender listed on their profile. ResultsWe identified 31 AUA and 20 EAU guidelines for inclusion. Median panel size was 19 (interquartile range [IQR]: 17; 21) with 12 (IQR: 10; 14) voting members. The average composition of voting panels was predominantly male (81.8%) and White (86.8%). Eleven guideline panels (21.6%) did not include any women, and nine (17.6%) panels had no representation of individuals from non-White groups. While gender distribution was similar among guidelines of the two organizations, the AUA included more voting members from non-White groups (14.3% versus 8.0%; p=0.010). Analysis of the AUA panel composition over time revealed stable proportions of female and non-White individuals. ConclusionBoth AUA and EAU guidelines exhibit insufficient representation of females and non-White individuals, with no evident improvement observed over time. Implementing more transparent processes that advocate for diverse panel representation may enhance the incorporation of stakeholder values and preferences, thereby improving the dissemination and adoption of guidelines.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call